ABEMACICLIB
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ABEMACICLIB |
| DrugBank ID | DB12001 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 30 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| juvenile onset parkinson disease 19a | TxGNN Knowledge Graph | L5 |
| atypical juvenile parkinsonism | TxGNN Knowledge Graph | L5 |
| early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph | L5 |
| parkinson disease | TxGNN Knowledge Graph | L5 |
| hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph | L5 |
| parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph | L5 |
| hereditary late onset parkinson disease | TxGNN Knowledge Graph | L5 |
| x-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph | L5 |
| methemoglobinemia | TxGNN Knowledge Graph | L5 |
| sulfhemoglobinemia | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11